- Home
- SLDB vs MAPS Comparison
SLDB vs MAPS Comparison
Compare SLDB & MAPS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SLDB
- MAPS
- Stock Information
- Founded
- SLDB 2013
- MAPS 2008
- Country
- SLDB United States
- MAPS United States
- Employees
- SLDB N/A
- MAPS N/A
- Industry
- SLDB Biotechnology: Biological Products (No Diagnostic Substances)
- MAPS Computer Software: Prepackaged Software
- Sector
- SLDB Health Care
- MAPS Technology
- Exchange
- SLDB Nasdaq
- MAPS Nasdaq
- Market Cap
- SLDB 124.7M
- MAPS 134.9M
- IPO Year
- SLDB 2018
- MAPS N/A
- Fundamental
- Price
- SLDB $5.78
- MAPS $1.39
- Analyst Decision
- SLDB Strong Buy
- MAPS Strong Buy
- Analyst Count
- SLDB 12
- MAPS 1
- Target Price
- SLDB $17.83
- MAPS $2.61
- AVG Volume (30 Days)
- SLDB 5.4M
- MAPS 1.4M
- Earning Date
- SLDB 03-12-2025
- MAPS 11-12-2024
- Dividend Yield
- SLDB N/A
- MAPS N/A
- EPS Growth
- SLDB N/A
- MAPS N/A
- EPS
- SLDB N/A
- MAPS N/A
- Revenue
- SLDB N/A
- MAPS $183,311,000.00
- Revenue This Year
- SLDB N/A
- MAPS N/A
- Revenue Next Year
- SLDB N/A
- MAPS $5.99
- P/E Ratio
- SLDB N/A
- MAPS N/A
- Revenue Growth
- SLDB N/A
- MAPS N/A
- 52 Week Low
- SLDB $2.88
- MAPS $0.70
- 52 Week High
- SLDB $15.05
- MAPS $1.65
- Technical
- Relative Strength Index (RSI)
- SLDB 69.94
- MAPS 51.53
- Support Level
- SLDB $3.15
- MAPS $1.31
- Resistance Level
- SLDB $7.20
- MAPS $1.47
- Average True Range (ATR)
- SLDB 0.63
- MAPS 0.08
- MACD
- SLDB 0.37
- MAPS 0.00
- Stochastic Oscillator
- SLDB 67.13
- MAPS 55.00
About SLDB Solid Biosciences Inc.
Solid Biosciences Inc is a life science company. It is engaged in the manufacturing of specialty and generic drugs. The company is involved in curing Duchenne muscular dystrophy (DMD), a genetic muscle-wasting disease predominantly affecting boys, with symptoms that usually manifest between three and five years of age. The company's pipeline products are the SB-001 and solid suit. The Company's singular focus is on developing treatments through gene therapy and other means for patients with neuromuscular and cardiac diseases. The company has categorized its programs into corrective therapies, disease-modifying therapies, and assistive devices.
About MAPS WM Technology Inc.
WM Technology Inc is a technology and software infrastructure provider to the cannabis industry. It comprises B2C platform Weedmaps, and B2B software WM Business. Its revenues are derived primarily from monthly subscriptions to Weedmaps for Business, featured and deal listings and other WM Ad solutions. The Weedmaps for Business subscriptions generally have one-month terms that automatically renew unless notice of cancellation is provided in advance. Featured and deal listings and other WM Ad solutions are offered as add-on products to the Weedmaps for Business subscriptions. Featured and deal listings provide customers with premium placement ad solutions and discount and promotion pricing tools. Other WM Ad solutions include banner ads and promotion tiles on our marketplace ads.